US2011081378A1PendingUtilityA1
Composition comprising iscom particles and live micro-organisms
Est. expiryMar 24, 2023(expired)· nominal 20-yr term from priority
A61P 31/16A61K 2039/5252A61K 39/145A61K 2039/55511A61P 31/20A61K 39/39C12N 7/00A61K 2039/70A61P 31/14A61K 2039/55577C12N 2760/18634C12N 2760/16134A61K 39/155A61K 2039/525
50
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Iscom particles can be used as an adjuvant for preparing of an antigenic composition which comprises live micro-organisms and/or killed micro-organisms and/or antigenic molecules. A composition may comprise at least one iscom particle and one or more live micro-organisms and/or killed micro-organisms and/or antigenic molecules. A kit can comprise at least one compartment containing at least one living organism and at least one compartment containing at least one iscom particle.
Claims
exact text as granted — not AI-modified1 - 17 . (canceled)
18 . A kit of parts comprising:
at least one compartment comprising at least one living micro-organism; and at least one compartment comprising at least one iscom particle.
19 . The kit according to claim 18 , further comprising at least one killed or inactivated micro-organism, which may be present in a further compartment or in the same compartment as the at least one compartment comprising the at least one iscom particle.
20 . The kit according to claim 18 or 19 , wherein the kit further comprises one or more antigenic molecules.
21 . The kit according to claim 18 or 19 , wherein the iscom particle is an iscom comprising at least one glycoside, at least one lipid, and at least one hydrophobic protein or peptide-containing antigen.
22 . The kit according to claim 21 , wherein the iscom particle comprises at least one glycoside fragment from Quillaja Saponaria Molina.
23 . The kit according to claim 22 , wherein the iscom particle comprises Fraction A and/or Fraction C of Quil A of Quillaja Saponaria Molina.
24 . The kit according to claim 18 or 19 , wherein the iscom particle is an iscom-matrix, comprising at least one glycoside and at least one lipid.
25 . The kit according to claim 24 , wherein the iscom particle comprises at least one glycoside fragment from Quillaja Saponaria Molina.
26 . The kit according to claim 25 , wherein the iscom particle comprises Fraction A and/or Fraction C of Quil A of Quillaja Saponaria Molina.
27 . The kit according to claim 18 or 19 , wherein the living micro-organism is a virus.
28 . The kit according to claim 18 or 19 , further comprising a pharmaceutically acceptable carrier, diluent, excipient, or additive.
29 . The kit according to claims 18 or 19 , wherein the kit has components that are used in a method of preparing an antigenic composition comprising at least one iscom particle and at least one living micro-organism.
30 . A method of use of the kit according to claim 18 comprising:
mixing the at least one living micro-organism and the at least one iscom particle in a single composition; and
administering the single composition to a host.
31 . A method of use of the kit according to claim 18 comprising co-administering to a host at the same event the at least one living micro-organism and the at least one iscom particle.
32 . The method according to claims 30 or 31 , wherein the host is a human.
33 . A method of use of the kit according to claim 19 comprising:
mixing the at least one living micro-organism, the at least one iscom particle, and the at least one killed or inactivated micro-organism in a single composition; and
administering the single composition to a host.
34 . A method of use of the kit according to claim 19 comprising co-administering to a host at the same event the at least one living micro-organism, the at least one iscom particle, and the at least one killed or inactivated micro-organism.
35 . The method according to claim 33 or 34 , wherein the host is a human.Join the waitlist — get patent alerts
Track US2011081378A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.